Andrew R. Blight
2010
In 2010, Andrew R. Blight earned a total compensation of $2M as Chief Scientific Officer at Acorda Therapeutics, a 51% increase compared to previous year.
Compensation breakdown
| Bonus | $162,397 |
|---|---|
| Option Awards | $811,848 |
| Salary | $339,417 |
| Stock Awards | $684,000 |
| Other | $7,350 |
| Total | $2,005,012 |
Blight received $811.8K in option awards, accounting for 40% of the total pay in 2010.
Blight also received $162.4K in bonus, $339.4K in salary, $684K in stock awards and $7.4K in other compensation.
Rankings
In 2010, Andrew R. Blight's compensation ranked 3,051st out of 10,439 executives tracked by ExecPay. In other words, Blight earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,051 out of 10,439 | 71st |
Division Manufacturing | 1,064 out of 3,838 | 72nd |
Major group Chemicals And Allied Products | 207 out of 921 | 78th |
Industry group Drugs | 109 out of 680 | 84th |
Industry Biological Products, Except Diagnostic Substances | 19 out of 142 | 87th |
Source: SEC filing on April 19, 2013.
Blight's colleagues
We found four more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2010.